CytomX Therapeutics Outlines 2024 Company Priorities and Milestones

Go back to CytomX Therapeutics Outlines 2024 Company Priorities and Milestones
Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) Delayed: 3.29 +0.01 (0.30%)
Previous Close $3.28    52 Week High $24.68 
Open $3.30    52 Week Low $9.10 
Day High $3.38    P/E N/A 
Day Low $3.18    EPS $0.00 
Volume 3,191,673